Astellas Pharma Makes Changes to Management Structure

Dr. Tadaaki Taniguchi joins as CMO, renames CAO & CECO to CPO & CECO and appoints CPO & CECO.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Astellas Pharma Inc. has made following changes to its management structure effective October 1, 2022. Top Management Dr. Tadaaki Taniguchi, MD, Ph.D, will be appointed as the new Chief Medical Officer (CMO). He joined Astellas as Executive Advisor on July 1, 2022. He is an internationally trained surgeon in the field of oncology with extensive industry experience in developing and commercializing innovative medicines as a senior leader in major global pharmaceutical companies. He will be ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters